VIB, through its associated funds like V-Bio Ventures and Biotope, focuses on investing in early-stage life sciences and agrifood biotech companies across Europe. Its strategy involves nurturing startups, often originating from VIB's own research, to translate scientific discoveries into commercial products with high growth potential.
100% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (100% of deals).
Portfolio
1
Fund Size
$185M
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Portfolio
1 investment
| Company | Round | Amount | Date |
|---|---|---|---|
| AAphea.Bio | Series B | $14M | Nov 2020 |
Top Co-Investors
Astanor1 shared
PMV1 shared
Last updated: 4 May 2026